BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 37717989)

  • 21. Novel interactions of the mineralocorticoid receptor.
    Fuller PJ
    Mol Cell Endocrinol; 2015 Jun; 408():33-7. PubMed ID: 25662276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineralocorticoid regulation of cell function: the role of rapid signalling and gene transcription pathways.
    Ong GS; Young MJ
    J Mol Endocrinol; 2017 Jan; 58(1):R33-R57. PubMed ID: 27821439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mineralocorticoid receptor binding, structure and function.
    Rogerson FM; Brennan FE; Fuller PJ
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):203-12. PubMed ID: 15134819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural determinants of activation of the mineralocorticoid receptor: an evolutionary perspective.
    Fuller PJ; Yao YZ; Yang J; Young MJ
    J Hum Hypertens; 2021 Feb; 35(2):110-116. PubMed ID: 32467588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of Micromilieu for Pathophysiologic Mineralocorticoid Receptor Activity-When the Mineralocorticoid Receptor Resides in the Wrong Neighborhood.
    Griesler B; Schuelke C; Uhlig C; Gadasheva Y; Grossmann C
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease.
    Parker BM; Wertz SL; Pollard CM; Desimine VL; Maning J; McCrink KA; Lymperopoulos A
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and molecular determinants of mineralocorticoid receptor signalling.
    Grossmann C; Almeida-Prieto B; Nolze A; Alvarez de la Rosa D
    Br J Pharmacol; 2022 Jul; 179(13):3103-3118. PubMed ID: 34811739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mineralocorticoid receptor actions in cardiovascular development and disease.
    Young MJ; Clyne CD
    Essays Biochem; 2021 Dec; 65(6):901-911. PubMed ID: 34414409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-function relationships in the mineralocorticoid receptor.
    Pippal JB; Fuller PJ
    J Mol Endocrinol; 2008 Dec; 41(6):405-13. PubMed ID: 18805937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Nongenomic effects via the mineralocorticoid receptor.
    Ruhs S; Nolze A; Hübschmann R; Grossmann C
    J Endocrinol; 2017 Jul; 234(1):T107-T124. PubMed ID: 28348113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural determinants of ligand binding to the mineralocorticoid receptor.
    Huyet J; Pinon GM; Fay MR; Rafestin-Oblin ME; Fagart J
    Mol Cell Endocrinol; 2012 Mar; 350(2):187-95. PubMed ID: 21820032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanistic aspects of mineralocorticoid receptor activation.
    Hellal-Levy C; Fagart J; Souque A; Rafestin-Oblin ME
    Kidney Int; 2000 Apr; 57(4):1250-5. PubMed ID: 10760050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology.
    Sevilla LM; Pérez P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards selectively modulating mineralocorticoid receptor function: lessons from other systems.
    Baxter JD; Funder JW; Apriletti JW; Webb P
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):151-65. PubMed ID: 15134814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mineralocorticoid receptor as a therapeutic target in chronic kidney disease and hypertension.
    Shibata S; Ishizawa K; Uchida S
    Hypertens Res; 2017 Mar; 40(3):221-225. PubMed ID: 27760997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple aspects of mineralocorticoid selectivity.
    Farman N; Rafestin-Oblin ME
    Am J Physiol Renal Physiol; 2001 Feb; 280(2):F181-92. PubMed ID: 11208593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Context-dependent mechanisms modulating aldosterone signaling in the kidney.
    Shibata S
    Clin Exp Nephrol; 2016 Oct; 20(5):663-670. PubMed ID: 26846783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mineralocorticoid receptor signaling: crosstalk with membrane receptors and other modulators.
    Meinel S; Gekle M; Grossmann C
    Steroids; 2014 Dec; 91():3-10. PubMed ID: 24928729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mineralocorticoids in the heart and vasculature: new insights for old hormones.
    Lother A; Moser M; Bode C; Feldman RD; Hein L
    Annu Rev Pharmacol Toxicol; 2015; 55():289-312. PubMed ID: 25251996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Coregulators as mediators of mineralocorticoid receptor signalling diversity.
    Fuller PJ; Yang J; Young MJ
    J Endocrinol; 2017 Jul; 234(1):T23-T34. PubMed ID: 28634265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.